Table of Contents Author Guidelines Submit a Manuscript
Journal of Diabetes Research
Volume 2016, Article ID 3805372, 6 pages
http://dx.doi.org/10.1155/2016/3805372
Research Article

Sex-Specific Association between Serum Uric Acid and Nonalcoholic Fatty Liver Disease in Type 2 Diabetic Patients

1Department of Endocrinology and Metabolism, Shanghai First People’s Hospital, Shanghai Jiao Tong University, Shanghai 200080, China
2Department of Endocrinology, Shanghai Songjiang Center Hospital, Shanghai 201600, China
3Department of Laboratory Medicine, Shanghai Songjiang Center Hospital, Shanghai 201600, China

Received 1 February 2016; Revised 11 May 2016; Accepted 15 May 2016

Academic Editor: Giovanni Annuzzi

Copyright © 2016 Nengguang Fan et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. K. Hassan, V. Bhalla, M. E. El Regal, and H. Hesham A-Kader, “Nonalcoholic fatty liver disease: a comprehensive review of a growing epidemic,” World Journal of Gastroenterology, vol. 20, no. 34, pp. 12082–12101, 2014. View at Publisher · View at Google Scholar · View at Scopus
  2. E. Fabbrini and F. Magkos, “Hepatic steatosis as a marker of metabolic dysfunction,” Nutrients, vol. 7, no. 6, pp. 4995–5019, 2015. View at Publisher · View at Google Scholar · View at Scopus
  3. H. Yuan, C. Yu, X. Li et al., “Serum uric acid levels and risk of metabolic syndrome: a dose-response meta-analysis of prospective studies,” The Journal of Clinical Endocrinology & Metabolism, vol. 100, no. 11, pp. 4198–4207, 2015. View at Publisher · View at Google Scholar
  4. W. G. Lima, M. E. Martins-Santos, and V. E. Chaves, “Uric acid as a modulator of glucose and lipid metabolism,” Biochimie, vol. 116, pp. 17–23, 2015. View at Publisher · View at Google Scholar
  5. Z. Liu, S. Que, L. Zhou, and S. Zheng, “Dose-response relationship of serum uric acid with metabolic syndrome and non-alcoholic fatty liver disease incidence: a meta-analysis of prospective studies,” Scientific Reports, vol. 5, article 14325, 2015. View at Publisher · View at Google Scholar · View at Scopus
  6. E. S. Kim, H. S. Kwon, C. W. Ahn et al., “Serum uric acid level is associated with metabolic syndrome and microalbuminuria in Korean patients with type 2 diabetes mellitus,” Journal of Diabetes and its Complications, vol. 25, no. 5, pp. 309–313, 2011. View at Publisher · View at Google Scholar · View at Scopus
  7. M. E. Kleber, G. Delgado, T. B. Grammer et al., “Uric acid and cardiovascular events: a Mendelian randomization study,” Journal of the American Society of Nephrology, vol. 26, no. 11, pp. 2831–2838, 2015. View at Publisher · View at Google Scholar · View at Scopus
  8. S. Kodama, K. Saito, Y. Yachi et al., “Association between serum uric acid and development of type 2 diabetes,” Diabetes Care, vol. 32, no. 9, pp. 1737–1742, 2009. View at Publisher · View at Google Scholar · View at Scopus
  9. V. Bhole, J. W. J. Choi, S. Woo Kim, M. De Vera, and H. Choi, “Serum uric acid levels and the risk of type 2 diabetes: a prospective study,” American Journal of Medicine, vol. 123, no. 10, pp. 957–961, 2010. View at Publisher · View at Google Scholar · View at Scopus
  10. H. L. Sun, D. Pei, K. H. Lue, and Y. Chen, “Uric acid levels can predict metabolic syndrome and hypertension in adolescents: a 10-year longitudinal study,” PLoS ONE, vol. 10, no. 11, Article ID e0143786, 2015. View at Publisher · View at Google Scholar
  11. Y. Li, C. Xu, C. Yu, L. Xu, and M. Miao, “Association of serum uric acid level with non-alcoholic fatty liver disease: a cross-sectional study,” Journal of Hepatology, vol. 50, no. 5, pp. 1029–1034, 2009. View at Publisher · View at Google Scholar · View at Scopus
  12. Y.-J. Lee, H.-R. Lee, J.-H. Lee, Y.-H. Shin, and J.-Y. Shim, “Association between serum uric acid and non-alcoholic fatty liver disease in Korean adults,” Clinical Chemistry and Laboratory Medicine, vol. 48, no. 2, pp. 175–180, 2010. View at Publisher · View at Google Scholar · View at Scopus
  13. I.-C. Hwang, S.-Y. Suh, A.-R. Suh, and H.-Y. Ahn, “The relationship between normal serum uric acid and nonalcoholic fatty liver disease,” Journal of Korean Medical Science, vol. 26, no. 3, pp. 386–391, 2011. View at Publisher · View at Google Scholar · View at Scopus
  14. J. W. Lee, Y. K. Cho, M. C. Ryan et al., “Serum uric acid as a predictor for the development of nonalcoholic fatty liver disease in apparently healthy subjects: a 5-year retrospective cohort study,” Gut and Liver, vol. 4, no. 3, pp. 378–383, 2010. View at Publisher · View at Google Scholar · View at Scopus
  15. C. Xu, C. Yu, L. Xu, M. Miao, and Y. Li, “High serum uric acid increases the risk for nonalcoholic fatty liver disease: a prospective observational study,” PLoS ONE, vol. 5, no. 7, Article ID e11578, 2010. View at Publisher · View at Google Scholar · View at Scopus
  16. Y. Xie, M. Wang, Y. Zhang et al., “Serum uric acid and non-alcoholic fatty liver disease in non-diabetic chinese men,” PLoS ONE, vol. 8, no. 7, Article ID e67152, 2013. View at Publisher · View at Google Scholar · View at Scopus
  17. S.-S. Moon, “Relationship between serum uric acid level and nonalcoholic fatty liver disease in pre- and postmenopausal women,” Annals of Nutrition and Metabolism, vol. 62, no. 2, pp. 158–163, 2013. View at Publisher · View at Google Scholar · View at Scopus
  18. F. Jian-gao, “Guidelines for management of nonalcoholic fatty liver disease: an updated and revised edition,” Zhonghua Gan Zang Bing Za Zhi, vol. 18, no. 3, pp. 163–166, 2010. View at Google Scholar · View at Scopus
  19. S.-J. Wu, G.-Q. Zhu, B.-Z. Ye et al., “Association between sex-specific serum uric acid and non-alcoholic fatty liver disease in Chinese adults: a large population-based study,” Medicine, vol. 94, article e802, 2015. View at Publisher · View at Google Scholar · View at Scopus
  20. Y. Zhu, Y. Hu, T. Huang et al., “High uric acid directly inhibits insulin signalling and induces insulin resistance,” Biochemical and Biophysical Research Communications, vol. 447, no. 4, pp. 707–714, 2014. View at Publisher · View at Google Scholar · View at Scopus
  21. L. L. Stein, M. H. Dong, and R. Loomba, “Insulin sensitizers in nonalcoholic fatty liver disease and steatohepatitis: current status,” Advances in Therapy, vol. 26, no. 10, pp. 893–907, 2009. View at Publisher · View at Google Scholar · View at Scopus
  22. Z. A. Ozturk and A. Kadayifci, “Insulin sensitizers for the treatment of non-alcoholic fatty liver disease,” World Journal of Hepatology, vol. 6, no. 4, pp. 199–206, 2014. View at Publisher · View at Google Scholar · View at Scopus
  23. A. K. Gupta, G. A. Bray, F. L. Greenway, C. K. Martin, W. D. Johnson, and S. R. Smith, “Pioglitazone, but not metformin, reduces liver fat in Type-2 diabetes mellitus independent of weight changes,” Journal of Diabetes and its Complications, vol. 24, no. 5, pp. 289–296, 2010. View at Publisher · View at Google Scholar · View at Scopus
  24. M. A. Lanaspa, L. G. Sanchez-Lozada, Y.-J. Choi et al., “Uric acid induces hepatic steatosis by generation of mitochondrial oxidative stress: potential role in fructose-dependent and -independent fatty liver,” The Journal of Biological Chemistry, vol. 287, no. 48, pp. 40732–40744, 2012. View at Publisher · View at Google Scholar · View at Scopus
  25. Y.-J. Choi, H.-S. Shin, H. S. Choi et al., “Uric acid induces fat accumulation via generation of endoplasmic reticulum stress and SREBP-1c activation in hepatocytes,” Laboratory Investigation, vol. 94, no. 10, pp. 1114–1125, 2014. View at Publisher · View at Google Scholar · View at Scopus
  26. X. Wan, C. Xu, Y. Lin et al., “Uric acid regulates hepatic steatosis and insulin resistance through the NLRP3 inflammasome-dependent mechanism,” Journal of Hepatology, vol. 64, no. 4, pp. 925–932, 2016. View at Publisher · View at Google Scholar
  27. D.-Q. Sun, S.-J. Wu, W.-Y. Liu et al., “Serum uric acid: a new therapeutic target for nonalcoholic fatty liver disease,” Expert Opinion on Therapeutic Targets, vol. 20, no. 3, pp. 375–387, 2016. View at Publisher · View at Google Scholar
  28. C. Xu, X. Wan, L. Xu et al., “Xanthine oxidase in non-alcoholic fatty liver disease and hyperuricemia: one stone hits two birds,” Journal of Hepatology, vol. 62, no. 6, article 5522, pp. 1412–1419, 2015. View at Publisher · View at Google Scholar · View at Scopus